E Trade Trust - No Fee International Index Fund (ETISX)
Fund Assets | 20.36M |
Expense Ratio | n/a |
Min. Investment | $0.00 |
Turnover | n/a |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | n/a |
Previous Close | 11.47 |
YTD Return | n/a |
1-Year Return | n/a |
5-Year Return | n/a |
52-Week Low | 10.22 |
52-Week High | 11.85 |
Beta (5Y) | n/a |
Holdings | 932 |
Inception Date | n/a |
About ETISX
The E*TRADE No Fee International Index Fund is an open-end mutual fund designed to provide investors with diversified exposure to companies domiciled in developed markets outside the United States. Managed by Morgan Stanley Investment Management, the fund’s primary objective is to closely track the performance of the Solactive GBS Developed Markets ex United States Large & Mid Cap USD Index NTR. This benchmark includes a broad range of large- and mid-cap equities across Europe, Asia-Pacific, and other developed regions, enabling investors to access international equities through a single investment vehicle. A notable feature of this fund is its 0% expense ratio and absence of commissions or investment minimums for E*TRADE clients, removing typical cost barriers and facilitating efficient international diversification. The fund generally holds hundreds of individual securities, including market leaders like SAP, Nestlé, ASML Holding, and Toyota Motor Corporation. As part of E*TRADE’s suite of no-fee index funds, it underscores a commitment to accessible, low-cost investing while leveraging the oversight and expertise of Morgan Stanley’s asset management division.
Top 10 Holdings
15.33% of assetsName | Symbol | Weight |
---|---|---|
Morgan Stanley & Co. LLC - Morgan Stanley Institutional Liquidity Funds - Government Portfolio | MVRXX | 5.18% |
SAP SE | SAP | 1.41% |
Nestlé S.A. | NESN | 1.33% |
ASML Holding N.V. | ASML | 1.23% |
Roche Holding AG | ROG | 1.09% |
Toyota Motor Corporation | 7203 | 1.05% |
Novartis AG | NOVN | 1.04% |
AstraZeneca PLC | AZN | 1.03% |
Novo Nordisk A/S | NOVO.B | 1.02% |
HSBC Holdings plc | HSBA | 0.95% |